Bristol-Myers Squibb Sees Mixed Options Activity Amid Analyst Ratings

Bristol-Myers Squibb (BMY) is experiencing a mix of bullish and bearish trading activity. With analysts divided on price targets, investors should weigh insights on options volume carefully.

Date: 31-12-2024

AI Rating: 5

Options Activity Overview
Financial activity around Bristol-Myers Squibb (BMY) shows a distinct mix of bullish and bearish sentiment among traders. The options chain indicates that 50% of trades are bullish while the other 50% are bearish, suggesting uncertainty in the market regarding the company's direction.

Prices and Volume
Recent trades include 4 puts valued at $239,888 and 6 calls valued at $312,412. The combined volume and open interest data hint at a price window of $43.0 to $75.0 for the stock. This indicates a strong interest from larger players in both bullish and bearish outlooks.

Recent Stock Performance
The current trading volume stands at 3,126,940, with the stock price slightly up by 0.74%, closing at $56.48. The Relative Strength Index (RSI) indicates a neutral position, implying that the stock is not in an overbought or oversold condition.

Analyst Ratings and Price Targets
Two professional analysts provided their insights, resulting in a price target average of $66.5. Notably, an upgrade to 'Buy' from Jefferies aligns with a revised target of $70, reflecting optimism. Conversely, B of A Securities has adjusted its rating to 'Neutral' with a lowered target of $63, highlighting a mix of expectations for the stock.

Stocks: BMY